Exelixis
Price & Volume
Stats
See more52W Range | $33.75-$57.57 |
Market Cap | $14.2B |
Shares Short | 28M |
Financials
See moreRevenue (12 Mos) | $2.3B |
Revenue Growth (YoY) | 10% |
Gross Profit (12 Mos) | $2.2B |
Diluted EPS | $2.99 |
News
See moreYahoo Finance • 20 days ago
Exelixis Announces STELLAR-303 Trial Results For Zanzalintinib Combination
Yahoo Finance • last month
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year
Yahoo Finance • last month
Exelixis, Inc. (EXEL): Renaissance Technologies Likes This Stock
Yahoo Finance • 2 months ago
Assessing Exelixis (EXEL) Valuation After Merck Zanzalintinib Keytruda Colorectal Cancer Collaboration
About
CEO | Dr. Michael M. Morrissey Ph.D. |
CFO | Mr. Christopher J. Senner |
Address | 1851 Harbor Bay Parkway, Alameda, CA, United States, 94502 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,077 |